Bragar Eagel & Squire, P.C. Is Investigating PAREXEL International Corporation (PRXL) On Behalf Of Stockholders And Encourages Investors To Contact The Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against PAREXEL International Corporation (NASDAQ:PRXL) concerning possible violations of the federal securities laws.

On August 30, 2016, post-market, PAREXEL announced that the Company was postponing the filing of its 2016 Annual Report on Form 10-K after receiving a report concerning an "incident of misappropriation of corporate funds by an employee in one of the Company's international operations." Following this news, PAREXEL shares declined $3.08 per share on August 31, 2016.

Then, on November 11, 2016, the Company announced it would not timely file its quarterly report for the fiscal first quarter of 2017 due to potential errors in the Company's revenue recognition. PAREXEL explained that such errors will impact revenue and earnings for the fiscal first quarter of 2017. PAREXEL anticipates correction of errors to have an adverse impact on revenue of approximately $6.7 million and on diluted earnings per share of approximately $0.08 for the quarter ended September 30, 2016. Following this news, PAREXEL shares declined $4.75 per share on November 11, 2016.

If you purchased PAREXEL securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact J. Brandon Walker, Esq. by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information, please go to www.bespc.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161114006603/en/
Copyright Business Wire 2010

If you liked this article you might like

These Are the Biggest Winners and Losers in Activist Investing This Year

These Are the Biggest Winners and Losers in Activist Investing This Year

With Hurricane Harvey, We Are in the Crosshairs of Volatility: Market Recon

With Hurricane Harvey, We Are in the Crosshairs of Volatility: Market Recon

EY's Greene Sees More Med Tech, CRO Deals Ahead

EY's Greene Sees More Med Tech, CRO Deals Ahead

Stocks Lower as Crude Oil Slides on Supply Concerns

Stocks Lower as Crude Oil Slides on Supply Concerns

Steep Selloff Pulls Crude Into Bear Market, S&P 500 and Nasdaq Trade Lower